Metronidazole Intravenous IV 500 mg/100 mL, 1 g/100 mL Suppliers & Bulk Manufacturers

Metronidazole intravenous IV is used to treat serious infections caused by anaerobic bacteria and certain parasites. It is commonly prescribed for intra-abdominal infections, gynecological infections, skin and soft tissue infections, bone and joint infections, and septicemia caused by susceptible organisms. It is also used in the treatment of infections such as bacterial vaginosis, trichomoniasis, and amoebiasis when oral therapy is not suitable. The IV formulation is typically administered in hospital settings for moderate to severe infections.

Metronidazole intravenous IV contains the active pharmaceutical ingredient metronidazole, a synthetic nitroimidazole antimicrobial agent. It works by entering microbial cells and disrupting DNA synthesis, which leads to the death of susceptible bacteria and protozoa.

Metronidazole intravenous IV is marketed under several trade names worldwide including Flagyl IV, Metronidazole Injection, Metrogyl IV, and other generic metronidazole infusion brands depending on the manufacturer and region.

One of the well-known brands, Flagyl IV, was originally marketed by Pfizer. It is also made by other manufacturers, including in India. We match each enquiry with licensed makers whose documents fit your market.

The generic name of Metronidazole intravenous IV is metronidazole.

Common brand names include Flagyl IV, Metrogyl IV, Metronidazole Injection, and other regional generic brands.

Metronidazole intravenous IV is manufactured in several countries including the United States, India, China, and multiple European countries by various pharmaceutical companies supplying hospital and clinical markets worldwide.

500 mg every 8 hours by intravenous infusion over 20–60 minutes, switching to oral as soon as possible.

Alcohol (disulfiram-like reaction) and warfarin (raised INR).

Ready-to-use 500 mg/100 ml bags and glass bottles, stored at room temperature and protected from light.